2 Comments

Is it possible that you're being a bit generous with Pfizer? Perhaps they don't want to open themselves to massive liability if something goes wrong. Some of the smaller, newer companies that are getting these huge grants from the government don't have as much to lose as a powerhouse like Pfizer. $2 billion is a very different number for Pfizer ($11.8 *billion* in revenues for quarter ending June, 2020) than it is for Novavax ($35.4 *million* in quarter ending June, 2020).

Expand full comment